R

Rapid Dose Therapeutics Corp
OTC:RDTCF

Watchlist Manager
Rapid Dose Therapeutics Corp
OTC:RDTCF
Watchlist
Price: 0.06 USD Market Closed
Market Cap: $7.5m

Wall St Price Targets

RDTCF Price Targets Summary
Rapid Dose Therapeutics Corp

There are no price targets for RDTCF.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Rapid Dose Therapeutics Corp Competitors:
Price Targets
PINT
Pantheon Infrastructure PLC
19% Upside
9930
Horizon Construction Development Ltd
72% Upside

Revenue
Forecast

74% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
74% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 74%. The projected CAGR for the next 6 years is 7%.

Gross Profit
Forecast

82% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
82% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 82%. The projected CAGR for the next 6 years is 18%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RDTCF's stock price target?
Not Available

RDTCF does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Rapid Dose Therapeutics Corp?
Projected CAGR
7%

Over the last 6 years, the compound annual growth rate for Revenue has been 74%. The projected CAGR for the next 6 years is 7%.

What is the Gross Profit forecast for Rapid Dose Therapeutics Corp?
Projected CAGR
18%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 82%. The projected CAGR for the next 6 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett